This page lists all pharmaceutical reports related to the field of Metabolic & Hormonal Disorders. The reports include market research reports and pipeline analyses.
Displaying 1 - 50 of 166 results
- The World Market for Prescription Orthopedic Drugs
- Advances in Ophthalmology: Markets in the Treatment of Eye Disorders and Corrective Vision
- The Protein Therapeutics Market: The Science and Business of a Growing Sector
- Critical Care Pharmaceutical Markets: A Strategic Analysis
- Diabetes and Diabetic Complications: Major World Markets
- Diabetes, Metabolic Syndrome and Cardiovascular Disease
- Over-the-Counter Diagnostic Products World Markets
- Women\'s Health: Diagnostic Testing
- Disposable Syringe Markets
- Blood Glucose Testing and Diabetes Management
- Stem Cell Markets
- The Global Endocrine Pharmaceutical Market 2005
- The World Diabetes Market, 2005-2011
- Cannabinoid Market Forecasts & Analysis to 2012
- Pipeline Insight: Dyslipidemia - Pipeline agents unlikely to rejuvenate the market
- Pipeline Insight: Osteoporosis - Intermittent dosing drives market growth
- Early Toxicology: Markets and Approaches
- Atherosclerosis - HDL, ApoA-I, Carotid MRI and 64-slice CT offer opportunities
- Obesity - Lack of Reimbursement Limits Market Potential
- Hormonal Contraceptives - New directions in a competitive market
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- Pipeline Insight: Insulins - Inhalable insulins unlikely to become blockbusters
- Antidiabetics - Patent expiries and cost containment initiatives balanced by pipeline products
- Non-insulin Antidiabetics - Type 2 diabetes unlikely to develop into a switch market
- Antidyslipidemics - The Generic Threat
- From Blockbuster to Nichebuster
- Monoclonal Antibodies 2007
- The Global Protein Therapeutics Market
- Biogenerics
- Metabolic Syndrome - Multiple definitions complicate treatment
- The Global Diabetes Market
- Drug Treatment in End-Stage Renal Disease
- Antidyslipidemics
- Inhalable Drug Delivery
- Therapeutic Vaccines
- Pipeline Insight: Osteoporosis
- Hypertension and Diabetic Kidney Disease - Prevalence, current treatment and future options
- Dyslipidemia - Statins Dominate Treatment Pathway
- Pipeline Insight: Antidyslipidemics
- Commercial Insight: Antidiabetics
- Commercial Insight: Antidyslipidemics
- HRT: Major Milestones - Current Perspectives on HRT and Menopause
- Monoclonal Antibodies: Financial and strategic analysis of the mAb market
- Osteoporosis - Risk management and reformulation offer best defense against generic onslaught
- Cell-Based Assays for Drug Discovery
- The Women’s Health Market Outlook to 2011
- Commercial Insight: Antidyslipidemics - The competitive cost-conscious antidyslipidemics market presents challenges
- TYPE 1 DIABETES - Therapy Area Pipeline Report
- DYSLIPIDEMIA - Therapy Area Pipeline Report
- HYPERLIPEMIA - Therapy Area Pipeline Report